New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge-Reference-Cited by-同舟云学术

New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge

Published:2018-03-15 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Almeida Ana Paula M. M.,Machado Leopoldo F. M.,Doro Daniel,Nascimento Frederico C.,Damasceno Leonardo,Gazzinelli Ricardo Tostes,Fernandes Ana Paula,Junqueira Caroline

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference69 articles.

1. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS One,2012

2. Deception and manipulation: the arms of Leishmania, a successful parasite;Cecílio;Front Immunol,2014

3. CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major;Wang;J Exp Med,1994